180 LIFE SCIENCES CORP (ATNF) Stock Price & Overview
NASDAQ:ATNF • US68236V3024
Current stock price
The current stock price of ATNF is 7.04 USD. Today ATNF is down by -7.49%. In the past month the price increased by 274.47%. In the past year, price increased by 291.11%.
ATNF Key Statistics
- Market Cap
- 42.522M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -12.78
- Dividend Yield
- N/A
ATNF Stock Performance
ATNF Stock Chart
ATNF Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to ATNF. When comparing the yearly performance of all stocks, ATNF is one of the better performing stocks in the market, outperforming 99.56% of all stocks.
ATNF Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ATNF. ATNF may be in some trouble as it scores bad on both profitability and health.
ATNF Earnings
ATNF Forecast & Estimates
ATNF Groups
Sector & Classification
ATNF Financial Highlights
Over the last trailing twelve months ATNF reported a non-GAAP Earnings per Share(EPS) of -12.78. The EPS increased by 54.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -160.7% | ||
| ROE | -319.99% | ||
| Debt/Equity | 0.12 |
ATNF Ownership
ATNF Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.05 | 368.574B | ||
| AMGN | AMGEN INC | 15.56 | 191.752B | ||
| GILD | GILEAD SCIENCES INC | 15.57 | 170.842B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.65 | 112.224B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.01 | 79.35B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45.37 | 41.318B | ||
| INSM | INSMED INC | N/A | 31.186B | ||
| NTRA | NATERA INC | N/A | 29.537B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 29.454B | ||
| BIIB | BIOGEN INC | 11 | 26.028B | ||
| UTHR | UNITED THERAPEUTICS CORP | 20.13 | 25.789B | ||
| MRNA | MODERNA INC | N/A | 21.305B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 19.501B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ATNF
Company Profile
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
Company Info
IPO: 2017-06-07
180 LIFE SCIENCES CORP
3000 El Camino Real, Bldg 4, Ste 200
Palo Alto CALIFORNIA 10019 US
CEO: James N. Woody
Employees: 4
Phone: 16505070669
180 LIFE SCIENCES CORP / ATNF FAQ
What does 180 LIFE SCIENCES CORP do?
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
Can you provide the latest stock price for 180 LIFE SCIENCES CORP?
The current stock price of ATNF is 7.04 USD. The price decreased by -7.49% in the last trading session.
Does 180 LIFE SCIENCES CORP pay dividends?
ATNF does not pay a dividend.
How is the ChartMill rating for 180 LIFE SCIENCES CORP?
ATNF has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the employee count for ATNF stock?
180 LIFE SCIENCES CORP (ATNF) currently has 4 employees.
Can you provide the market cap for 180 LIFE SCIENCES CORP?
180 LIFE SCIENCES CORP (ATNF) has a market capitalization of 42.52M USD. This makes ATNF a Nano Cap stock.